Mycotoxins

Section Information

The “Mycotoxins” section of Toxins is designated to the submission of high quality manuscripts that report new investigations into all aspects of research on mycotoxins, including but not limited to: mechanisms of action; mycotoxin transport; mycotoxin detection strategies; structure–activity relationships; binding agents and deactivators of mycotoxins; mycotoxin biosynthesis; mycotoxin evolution and classification; and clinical effects and case reports. The editors will also consider reviews that summarize current thinking or present controversial viewpoints to stimulate further discussion. Short communications that report important self-contained observations are also welcome.

Aflatoxins; Alternaria; animal modelling; antibodies; apoptosis; aptamers; Aspergillus; biochemistry; bioinformatics; biosynthesis; carcinogen; classification; citrinin; clinical studies; contamination, comet assay; coumarins; crops; cytotoxicity; detection methods; diagnostic methods; DNA adducts; DNA binding; DNA cleavage; DNA damage; environmental contaminants; ergot alkaloids; exposure; fungi; fusarium; gene expression profiling; hepatotoxins; humidity; immunotoxins, intracellular transport; in vitro diagnostics; lactone; maize; mass spectrometry; mechanism of action; metabolism; molecular modelling; mutagenicity; mycoses; mycotoxicoses; natural products; necrosis; nephrotoxicity; neurotoxins; NMR; patulin, pathology; PCR; peanuts; peptides; Penicillum; pharmacology; pharmacokinetics; physiology; polyketides; protein; proteomics; purification; ochratoxins, oxidative stress; regulations; receptor interaction; spores; therapeutic intervention; therapeutic molecules; teratogens; toxin; trichothecenes; wheat; X-ray crystallography; zearalenone